Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Mol Psychiatry ; 20(4): 482-9, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24912492

RESUMO

Central nervous glycogen synthase kinase 3ß (GSK3ß) is implicated in a number of neuropsychiatric diseases, such as bipolar disorder, depression, schizophrenia, fragile X syndrome or anxiety disorder. Many drugs employed to treat these conditions inhibit GSK3ß either directly or indirectly. We studied how conditional knockout of GSK3ß affected structural synaptic plasticity. Deletion of the GSK3ß gene in a subset of cortical and hippocampal neurons in adult mice led to reduced spine density. In vivo imaging revealed that this was caused by a loss of persistent spines, whereas stabilization of newly formed spines was reduced. In electrophysiological recordings, these structural alterations correlated with a considerable drop in the frequency and amplitude of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor-dependent miniature excitatory postsynaptic currents. Expression of constitutively active ß-catenin caused reduction in spine density and electrophysiological alterations similar to GSK3ß knockout, suggesting that the effects of GSK3ß knockout were mediated by the accumulation of ß-catenin. In summary, changes of dendritic spines, both in quantity and in morphology, are correlates of experience-dependent synaptic plasticity; thus, these results may help explain the mechanism of action of psychotropic drugs inhibiting GSK3ß.


Assuntos
Espinhas Dendríticas/fisiologia , Potenciais Pós-Sinápticos Excitadores/genética , Regulação da Expressão Gênica/genética , Quinase 3 da Glicogênio Sintase/deficiência , Neurônios/citologia , beta Catenina/metabolismo , Animais , Antineoplásicos Hormonais/farmacologia , Proteínas de Bactérias/genética , Proteínas de Bactérias/metabolismo , Córtex Cerebral/citologia , Fármacos Atuantes sobre Aminoácidos Excitatórios/farmacologia , Potenciais Pós-Sinápticos Excitadores/efeitos dos fármacos , Antagonistas GABAérgicos/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Quinase 3 da Glicogênio Sintase/genética , Glicogênio Sintase Quinase 3 beta , Hipocampo/citologia , Técnicas In Vitro , Proteínas Luminescentes/genética , Proteínas Luminescentes/metabolismo , Camundongos , Camundongos Transgênicos , Neurônios/efeitos dos fármacos , Técnicas de Patch-Clamp , Picrotoxina/farmacologia , Tamoxifeno/farmacologia
2.
Gene Ther ; 18(7): 656-65, 2011 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-21368902

RESUMO

Fragments of botulinum neurotoxin (BoNT) have been explored as potential targeting moieties and carriers of biomolecules into neurons, although with lower binding and translocation efficiency compared with intact proteins. This study exploits a detoxified recombinant form of full-length BoNT/B (BoTIM/B) fused with core streptavidin (CS-BoTIM/B) for lentiviral targeting to central and autonomic neurons. CS-BoTIM/B underwent an activity-dependent entry into cultured spinal cord neurons. Coupling CS-BoTIM/B to biotinylated lentivirus-encoding green fluorescent protein (GFP) endowed considerable neuron selectivity to the vector as evident from the preferential expression of the reporter in neurons co-cultured with skeletal muscle cells. CS-BoTIM/B-guided lentiviral transduction with the expression of a SNARE protein, SNAP-25 (S25), rendered non-susceptible to proteolysis by three BoNT serotypes, yielded a sizable decrease in cleaved S25 upon exposure of spinal cord neurons to these toxins. This was accompanied by synaptic transmission being spared from blockade by BoNT/A or BoNT/E, reflecting adequate translation and functional competence of recombinant multi-toxin-resistant S25. The augmented neurotropism conveyed on the lentivirus by CS-BoTIM/B was also demonstrated in vivo through enhanced expression of a reporter in intramural ganglionic neurons in the rat trachea, after injection of the targeted GFP-encoding lentivirus. Thus, a novel and realistic prospect for gene therapy of peripheral neuropathies is offered in this study through lentiviral targeting to neurons by CS-BoTIM/B.


Assuntos
Toxinas Botulínicas/farmacologia , Gânglios Autônomos/metabolismo , Marcação de Genes , Técnicas de Transferência de Genes , Vetores Genéticos , Interneurônios/metabolismo , Lentivirus/genética , Medula Espinal/metabolismo , Toxinas Botulínicas Tipo A , Proteínas de Fluorescência Verde/genética , Especificidade de Órgãos , Proteínas Recombinantes/farmacologia , Medula Espinal/citologia , Estreptavidina , Transmissão Sináptica , Proteína 25 Associada a Sinaptossoma/metabolismo
3.
Neuroscience ; 129(3): 639-46, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15541885

RESUMO

Monosynaptic excitatory postsynaptic potentials (EPSPs) evoked by stimulating ipsilateral ventrolateral column (VLC) in the thoracic section were recorded in lumbar motoneurons within the isolated spinal cord of the frog Rana ridibunda. Bath application of the selective GABAB receptor agonist (-)-baclofen (0.05 mM) caused a reduction in the peak amplitude of VLC EPSP. Baclofen did not cause any consistent change in the membrane potential or in the EPSP waveform within frog motoneurones. The selective GABA(B) receptor antagonist saclofen (0.1 mM) completely blocked the effect of (-)-baclofen on VLC EPSP. A decrease in VLC EPSP peak amplitude was also observed during GABA (0.5 mM) application. Unlike (-)-baclofen, inhibition of VLC EPSP induced by GABA was accompanied by a shortening of the EPSP time course and a reduction in membrane input resistance within lumbar motoneurons. The decrease in VLC EPSP peak amplitude induced by (-)-baclofen and GABA was accompanied by an increase in the paired-pulse facilitation. These data provide evidence for a dual pre- and postsynaptic GABAergic inhibition of the VLC monosynaptic EPSP in lumbar motoneurons within the frog spinal cord.


Assuntos
Baclofeno/análogos & derivados , Potenciais Pós-Sinápticos Excitadores/efeitos dos fármacos , Neurônios Motores/efeitos dos fármacos , Medula Espinal/citologia , Sinapses/efeitos dos fármacos , Ácido gama-Aminobutírico/farmacologia , Animais , Baclofeno/farmacologia , Interações Medicamentosas , Estimulação Elétrica/métodos , Potenciais Evocados/efeitos dos fármacos , Potenciais Evocados/efeitos da radiação , Potenciais Pós-Sinápticos Excitadores/efeitos da radiação , Agonistas GABAérgicos , Antagonistas GABAérgicos/farmacologia , Técnicas In Vitro , Região Lombossacral , Neurônios Motores/efeitos da radiação , Rana ridibunda , Sinapses/efeitos da radiação , Transmissão Sináptica/efeitos dos fármacos
5.
Ross Fiziol Zh Im I M Sechenova ; 90(8): 1033-40, 2004 Aug.
Artigo em Russo | MEDLINE | ID: mdl-15552369

RESUMO

The effects of GABA, bicuculline and 5-HT on primary afferents in the isolated spinal cord of the frog Rana ridibunda were studied. Bath application of GABA (1 mM) reduced the primary afferent depolarisation (PAD) in IX segment of the spinal cord evoked by X dorsal root stimulation (57 +/- 8% of initial level, n = 5, p < 0.05). The action potentials (AP) recorded in dorsal root afferents was also suppressed under the GABA action (74 +/- 9%, p < 0.05). Bath application of bicuculline (50 microM) reduced the PAD (21 +/- 7%), n = 6, p < 0.05), meanwhile the AP in dorsal root afferents was resistant against the bicuculline action. Bath application of 5-HT (25 microM) depressed the PAD (34 +/- 7%, n = 7, p < 0.05) and the amplitude of the AP recorded from the single afferent fibre in dorsal column (76 +/- 6%, n = 7, p < 0.05). In contrast to GABA, 5-HT more effectively suppressed the late phase of the PAD evoked by X dorsal root stimulation and caused (76 +/- 6%, n = 7, p < 0.05) an alteration of the AP shape. All effects induced by these drugs were reversible. The mechanisms of GABA and 5-HT modulation of spinal cord afferent income are discussed.


Assuntos
Potenciais de Ação/efeitos dos fármacos , Antagonistas GABAérgicos/farmacologia , Receptores de GABA-A/metabolismo , Receptores de Serotonina/metabolismo , Serotonina/farmacologia , Raízes Nervosas Espinhais/efeitos dos fármacos , Ácido gama-Aminobutírico/farmacologia , Animais , Bicuculina/farmacologia , Técnicas In Vitro , Neurônios Aferentes/efeitos dos fármacos , Neurônios Aferentes/fisiologia , Rana ridibunda , Medula Espinal/efeitos dos fármacos , Raízes Nervosas Espinhais/fisiologia
6.
Ross Fiziol Zh Im I M Sechenova ; 88(7): 817-28, 2002 Jul.
Artigo em Russo | MEDLINE | ID: mdl-12238349

RESUMO

(-)-Baclophen was found to depress in a dose-dependent and reversible way the excitatory post-synaptic potentials (EPSPS) of motor neurons and the ventral root potentials evoked by stimulation of fibres of the ipsi- and contralateral ventral columns. The (-)-baclophen depressing effect could be eliminated with saclophen. Picrotoxin eliminated the depressing effect of the GABA on the descending EPSPS. Depressing effects of (-)-baclophen and GABA upon the ventral root potentials were also shown. The data obtained in pharmacological analysis corroborate to a certain extent existence of the GABAB receptor presynaptic inhibition in descending fibres monosynaptically corrected with the spinal cord motor neurons in the frog Rana ridibunda.


Assuntos
Potenciais Pós-Sinápticos Excitadores/fisiologia , Fibras Nervosas/fisiologia , Inibição Neural/fisiologia , Receptores de GABA-B/fisiologia , Medula Espinal/fisiologia , Potenciais de Ação/fisiologia , Animais , Potenciais Pós-Sinápticos Excitadores/efeitos dos fármacos , Agonistas GABAérgicos/farmacologia , Antagonistas GABAérgicos/farmacologia , Agonistas dos Receptores de GABA-B , Antagonistas de Receptores de GABA-B , Técnicas In Vitro , Neurônios Motores/fisiologia , Neurônios Eferentes/fisiologia , Rana ridibunda , Medula Espinal/citologia , Raízes Nervosas Espinhais/fisiologia , Sinapses/fisiologia , Ácido gama-Aminobutírico/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA